Phase II trial of AMG 221 in patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2011
At a glance
- Drugs AMG 221 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Amgen
- 29 Apr 2011 Status changed from planning to unconfirmed (trial never initiated and development of AMG 221 has been discontinued).
- 21 Jan 2010 New trial record.